Literature DB >> 12706951

Diagnosis and definition of treatment-resistant depression.

Maurizio Fava1.   

Abstract

Treatment-resistant depression (TRD) typically refers to inadequate response to at least one antidepressant trial of adequate doses and duration. TRD is a relatively common occurrence in clinical practice, with up to 50% to 60% of the patients not achieving adequate response following antidepressant treatment. A diagnostic re-evaluation is essential to the proper management of these patients. In particular, the potential role of several contributing factors, such as medical and psychiatric comorbidity, needs to be taken into account. An accurate and systematic assessment of TRD is a challenge to both clinicians and researchers, with the use of clinician-rated or self-rated instruments being perhaps quite helpful. It is apparent that there may be varying degrees of treatment resistance. Some staging methods to assess levels of treatment resistance in depression are being developed, but need to be tested empirically. Copyright 2003 Society of Biological Psychiatry

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706951     DOI: 10.1016/s0006-3223(03)00231-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  289 in total

Review 1.  Acupuncture for depression: a critique of the evidence base.

Authors:  Sylvia Schroer; Joy Adamson
Journal:  CNS Neurosci Ther       Date:  2010-11-21       Impact factor: 5.243

2.  Beyond Depression: Towards a Process-Based Approach to Research, Diagnosis, and Treatment.

Authors:  Marie J C Forgeard; Emily A P Haigh; Aaron T Beck; Richard J Davidson; Fritz A Henn; Steven F Maier; Helen S Mayberg; Martin E P Seligman
Journal:  Clin Psychol (New York)       Date:  2011-12

3.  Why Psychiatrists are Reluctant to Diagnose: Borderline Personality Disorder.

Authors:  Joel Paris
Journal:  Psychiatry (Edgmont)       Date:  2007-01

4.  Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.

Authors:  Roy H Perlis; Rudolf Uher; Michael Ostacher; Joseph F Goldberg; Madhukar H Trivedi; A John Rush; Maurizio Fava
Journal:  Arch Gen Psychiatry       Date:  2010-12-06

Review 5.  Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain.

Authors:  Yi Zheng; Xijing Chen; Leslie Z Benet
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

6.  Anti-Oxidative Effects of Melatonin Receptor Agonist and Omega-3 Polyunsaturated Fatty Acids in Neuronal SH-SY5Y Cells: Deciphering Synergic Effects on Anti-Depressant Mechanisms.

Authors:  Senthil Kumaran Satyanarayanan; Yin-Hwa Shih; Yu-Chuan Chien; Shih-Yi Huang; Piotr Gałecki; Siegfried Kasper; Jane Pei-Chen Chang; Kuan-Pin Su
Journal:  Mol Neurobiol       Date:  2018-02-03       Impact factor: 5.590

Review 7.  HCN Channel Targets for Novel Antidepressant Treatment.

Authors:  Stacy M Ku; Ming-Hu Han
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

8.  Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns.

Authors:  Michael Paulzen; Ekkehard Haen; Benedikt Stegmann; Stefan Unterecker; Christoph Hiemke; Gerhard Gründer; Georgios Schoretsanitis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-10-01       Impact factor: 5.270

9.  A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned.

Authors:  Charles H Bombardier; Jesse R Fann; Catherine S Wilson; Allen W Heinemann; J Scott Richards; Ann Marie Warren; Larry Brooks; Catherine A Warms; Nancy R Temkin; Denise G Tate
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

10.  Effects of electro-acupuncture on personality traits in depression: a randomized controlled study.

Authors:  Wei-dong Wang; Xue-yu Lu; Siu-man Ng; Lan Hong; Yang Zhao; Ying-na Lin; Fang Wang
Journal:  Chin J Integr Med       Date:  2013-10-04       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.